Abiopharma

🔍 MYERS FRANKLIN (Executive)

Company: HF Sinclair Corp (DINO)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 15,000 shares of Common Stock at $85.3 per share (Direct)
  Date: 2026-08-11 | Code: P | equity_swap_involved: false | shares_owned_after: 194,841.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $85.20 to $85.35, inclusive. The reporting person undertakes to provide to HF Sinclair Corporation, any security holder of HF Sinclair Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.